BioCentury
ARTICLE | Company News

Celyad, Institut Curie deal

April 4, 2016 7:00 AM UTC

Celyad and Institut Curie partnered to develop Celyad’s NKR-T program. NKR-2, which comprises autologous chimeric antigen receptor (CAR) T cells targeting killer cell lectin-like receptor subfamily ...